0001209191-23-035589.txt : 20230608 0001209191-23-035589.hdr.sgml : 20230608 20230608204606 ACCESSION NUMBER: 0001209191-23-035589 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230606 FILED AS OF DATE: 20230608 DATE AS OF CHANGE: 20230608 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MCDADE MARK CENTRAL INDEX KEY: 0001242126 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40655 FILM NUMBER: 231003606 MAIL ADDRESS: STREET 1: C/O PROTINE DESIGN LAB STREET 2: 7442 NORTH MARCER WAY CITY: MERCER ISLAND STATE: WA ZIP: 98040 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Icosavax, Inc. CENTRAL INDEX KEY: 0001786255 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1930 BOREN AVE., SUITE 1000 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: (206) 737-0085 MAIL ADDRESS: STREET 1: 1930 BOREN AVE., SUITE 1000 CITY: SEATTLE STATE: WA ZIP: 98101 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-06 0 0001786255 Icosavax, Inc. ICVX 0001242126 MCDADE MARK C/O QIMING U.S. VENTURES MANAGEMENT, LLC 11100 NE 8TH STREET, SUITE 200 BELLEVUE WA 98004 1 0 0 0 0 Stock Option (Right to Buy) 9.89 2023-06-06 4 A 0 17000 0.00 A 2033-06-05 Common Stock 17000 17000 D The option shall vest in equal monthly installments over the twelve (12) months following the date of grant (or, in the event the next annual meeting of the Company's stockholders occurs prior to the first anniversary of the date of grant, any remaining unvested portion of the option will vest on the date of such annual meeting of the Company's stockholders), subject to continued service through the applicable vesting date. /s/ Mark McDade 2023-06-08